// AST – IMS - [DMinute_ROS]

Quaker Capital Investments Has Lifted Spirit Airls (SAVE) Position by $654,444 as Market Valuation Rose; Shelter Ins Retirement Plan Has Lowered Its Abbvie (ABBV) Stake by $772,800 as Share Value Declined

AbbVie Inc. (NYSE:ABBV) Logo

Shelter Ins Retirement Plan decreased its stake in Abbvie Inc (ABBV) by 11.1% based on its latest 2018Q2 regulatory filing with the SEC. Shelter Ins Retirement Plan sold 8,400 shares as the company’s stock declined 4.45% while stock markets rallied. The institutional investor held 67,300 shares of the major pharmaceuticals company at the end of 2018Q2, valued at $6.24M, down from 75,700 at the end of the previous reported quarter. Shelter Ins Retirement Plan who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $141.80 billion market cap company. The stock increased 4.85% or $4.36 during the last trading session, reaching $94.27. About 12.03 million shares traded or 90.07% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 6.26% since December 2, 2017 and is uptrending. It has underperformed by 9.36% the S&P500. Some Historical ABBV News: 15/05/2018 – AbbVie Presenting at Bank of America Conference Tomorrow; 25/04/2018 – ABBVIE INC – SIGNIFICANTLY MORE PATIENTS RECEIVING UPADACITINIB ACHIEVED ACR50, ACR70 AND CLINICAL REMISSION AT WEEK 12 COMPARED TO PLACEBO; 26/04/2018 – AbbVie to Commence Self-Tender Offer for Up to $7.5B of Common Stk; 08/05/2018 – OncoSec Expands Relationship with Merck, Announces Clinical Collaboration to Evaluate Combination of lmmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer; 25/04/2018 – ABBVIE SUBMITS BLA FOR PLAQUE PSORIASIS DRUG RISANKIZUMAB; 16/04/2018 – Cyclacel Pharmaceuticals: Will Soon Start Clinical Study Testing CYC065 Combined With Venetoclax in Patients With Relapsed/refractory Chronic Lymphocytic Leukemia; 16/04/2018 – Shire sells cancer drugs to Servier for $2.4 bln as Takeda circles; 25/04/2018 – ABBVIE – IN SELECT-SUNRISE, UPADACITINIB MET PRIMARY ENDPOINT OF ACR20 ACROSS ALL DOSES AT WEEK 12; 21/05/2018 – LANNETT – EXPECT TO COMMENCE MARKETING SEVERAL PRODUCTS INCLUDING DRONABINOL CAPSULES OVER COURSE OF YEAR; 22/03/2018 – ABBVIE INC – SAFETY DATA IN TRINITY STUDY WERE CONSISTENT WITH PREVIOUSLY REPORTED STUDIES OF ROVA-T

Quaker Capital Investments Llc increased its stake in Spirit Airls Inc (SAVE) by 4.05% based on its latest 2018Q2 regulatory filing with the SEC. Quaker Capital Investments Llc bought 18,179 shares as the company’s stock rose 30.32% with the market. The institutional investor held 467,041 shares of the transportation company at the end of 2018Q2, valued at $16.98 million, up from 448,862 at the end of the previous reported quarter. Quaker Capital Investments Llc who had been investing in Spirit Airls Inc for a number of months, seems to be bullish on the $4.38B market cap company. The stock increased 3.42% or $2.12 during the last trading session, reaching $64.12. About 726,531 shares traded. Spirit Airlines, Inc. (NASDAQ:SAVE) has risen 39.84% since December 2, 2017 and is uptrending. It has outperformed by 24.22% the S&P500. Some Historical SAVE News: 11/05/2018 – Spirit Airlines Brings Wi-Fi to America’s Discount-Flying Masses; 06/03/2018 – SPIRIT AIRLINES SAYS CURRENT 2019E AIRCRAFT DELEVERIES EQUATE TO LESS THAN 10 PCT CAPACITY GROWTH IN 2019; 26/04/2018 – Spirit Airlines 1Q Adj EPS 44c; 28/03/2018 – Chicago O’Hare $8.5 bln expansion plan approved by city council; 12/04/2018 – lt’s Go Season! Spirit Airlines Gives Away Free Flights to Celebrate More than a Dozen New Routes for Sizzling Summer Travel; 21/04/2018 – DJ Spirit Airlines Inc, Inst Holders, 1Q 2018 (SAVE); 12/03/2018 – Fitch Affirms Spirit Airlines at ‘BB+’; Revises Outlook to Negative; 11/05/2018 – Spirit Airlines would be the first U.S. ultra-low cost carrier to offer Wi-Fi on board; 20/04/2018 – Consolidated Research: 2018 Summary Expectations for Keane Group, Spirit Airlines, Farmland Partners, Arrow Electronics, Semgro; 26/04/2018 – SPIRIT AIRLINES INC – SEES FY 2018 TOTAL CAPITAL EXPENDITURES OF $1,003 MLN

More notable recent Spirit Airlines, Inc. (NYSE:SAVE) news were published by: Seekingalpha.com which released: “Impressive Capital Management Could Save Vitamin Shoppe – Seeking Alpha” on November 11, 2018, also Benzinga.com with their article: “5 Biggest Price Target Changes For Tuesday – Benzinga” published on November 27, 2018, Globenewswire.com published: “More Go for JAX! Spirit Airlines Celebrates Veterans Day with More Routes and Commitment to Our Nation’s Heroes – GlobeNewswire” on November 12, 2018. More interesting news about Spirit Airlines, Inc. (NYSE:SAVE) were released by: 247Wallst.com and their article: “Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, CME, DaVita, Skyworks, Spirit Air, AMD, Nvidia and More – 24/7 Wall St.” published on November 28, 2018 as well as Fool.com‘s news article titled: “Snap Tries to Save Spectacles (Again) With New AR Features – The Motley Fool” with publication date: November 26, 2018.

Investors sentiment increased to 1 in Q2 2018. Its up 0.10, from 0.9 in 2018Q1. It increased, as 38 investors sold SAVE shares while 54 reduced holdings. 19 funds opened positions while 73 raised stakes. 77.03 million shares or 8.06% more from 71.29 million shares in 2018Q1 were reported. Tyvor Capital Lc holds 1.28 million shares or 9.03% of its portfolio. Quantitative Systematic Strategies Ltd Liability Com holds 28,008 shares or 0.19% of its portfolio. Dimensional Fund Advsrs LP has 0.06% invested in Spirit Airlines, Inc. (NYSE:SAVE). Aperio Group Ltd Limited Liability Company reported 8,324 shares or 0% of all its holdings. First Tru Advisors Lp has 847,463 shares for 0.06% of their portfolio. Country Club Tru Na has 13,665 shares. Rbf Ltd Com holds 0.46% or 107,000 shares in its portfolio. Bancorp Of America Corporation De invested in 121,195 shares or 0% of the stock. Kempen Capital Mgmt Nv accumulated 252,781 shares. Cambridge Investment owns 27,204 shares. 22,142 were accumulated by Metropolitan Life Ins New York. D E Shaw Co holds 0% or 72,730 shares in its portfolio. Florida-based Raymond James Associate has invested 0% in Spirit Airlines, Inc. (NYSE:SAVE). 137,290 were accumulated by Boston Partners. Blackrock has 4.47 million shares for 0.01% of their portfolio.

Among 19 analysts covering Spirit Airlines (NASDAQ:SAVE), 10 have Buy rating, 0 Sell and 9 Hold. Therefore 53% are positive. Spirit Airlines had 114 analyst reports since August 18, 2015 according to SRatingsIntel. Morgan Stanley maintained the shares of SAVE in report on Monday, October 23 with “Equal-Weight” rating. The firm has “Buy” rating by Buckingham Research given on Thursday, August 30. Morgan Stanley maintained it with “Equal-Weight” rating and $44 target in Thursday, April 12 report. The rating was downgraded by Buckingham Research to “Hold” on Friday, July 28. Citigroup maintained the stock with “Neutral” rating in Friday, September 25 report. JP Morgan upgraded it to “Overweight” rating and $82 target in Wednesday, November 28 report. Credit Suisse maintained it with “Neutral” rating and $46 target in Tuesday, April 12 report. As per Tuesday, August 1, the company rating was upgraded by JP Morgan. The rating was maintained by Citigroup on Tuesday, April 19 with “Buy”. Citigroup upgraded the shares of SAVE in report on Friday, July 28 to “Buy” rating.

Since September 4, 2018, it had 0 buys, and 4 insider sales for $361,380 activity. 566 shares were sold by Wiggins Rocky, worth $27,106 on Tuesday, September 11. $35,648 worth of Spirit Airlines, Inc. (NYSE:SAVE) was sold by JOHNSON ROBERT D.

Among 25 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 12 Hold. Therefore 40% are positive. Abbvie Inc had 103 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Thursday, May 25. The firm has “Buy” rating by Goldman Sachs given on Friday, March 10. The rating was downgraded by PiperJaffray on Friday, June 1 to “Neutral”. Argus Research maintained it with “Buy” rating and $130 target in Monday, June 11 report. Credit Suisse maintained it with “Neutral” rating and $104 target in Friday, April 27 report. The firm has “Neutral” rating given on Friday, December 18 by Atlantic Securities. The stock of AbbVie Inc. (NYSE:ABBV) has “Market Perform” rating given on Monday, June 6 by Cowen & Co. The rating was maintained by Morgan Stanley with “Equal-Weight” on Tuesday, January 30. The rating was initiated by Deutsche Bank with “Hold” on Tuesday, March 15. As per Monday, January 29, the company rating was maintained by Credit Suisse.

Investors sentiment increased to 0.94 in 2018 Q2. Its up 0.24, from 0.7 in 2018Q1. It increased, as 55 investors sold ABBV shares while 614 reduced holdings. 107 funds opened positions while 524 raised stakes. 1.00 billion shares or 5.08% less from 1.06 billion shares in 2018Q1 were reported. Cypress Asset Tx reported 11,110 shares. Smith Salley Associate has invested 1.77% in AbbVie Inc. (NYSE:ABBV). Bridgeway Capital Management holds 0.14% or 148,800 shares in its portfolio. Douglass Winthrop Ltd Liability owns 66,400 shares or 0.28% of their US portfolio. 11,843 were accumulated by Northstar Investment Advsrs Ltd Limited Liability Company. Clinton Group Inc has invested 0% of its portfolio in AbbVie Inc. (NYSE:ABBV). Evanson Asset Management Lc, a California-based fund reported 10,961 shares. Cornerstone Inc invested in 1.31% or 117,000 shares. Spears Abacus Advsr Limited Liability Corporation accumulated 3,156 shares. Jpmorgan Chase And invested 0.14% of its portfolio in AbbVie Inc. (NYSE:ABBV). Blackhill Inc stated it has 2.98% of its portfolio in AbbVie Inc. (NYSE:ABBV). 1.38M were reported by Cincinnati Insurance. Navellier And Incorporated invested in 0.38% or 29,718 shares. Independent Investors, a New York-based fund reported 54,400 shares. Bar Harbor Tru Svcs, Maine-based fund reported 2,222 shares.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “Biotech Giant Should Deliver Mid-Teens Total Returns – Seeking Alpha” on November 15, 2018, also Globenewswire.com with their article: “The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, MGTI, ACHC, JT and HTHT – GlobeNewswire” published on November 21, 2018, Fool.com published: “Better Buy: Eli Lilly and Company vs. AbbVie Inc. – Motley Fool” on November 07, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “SunTrust: Venclexta could add $1B+ for AbbVie – Seeking Alpha” published on November 23, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie teams up with Mission Therapeutics in Alzheimer’s and Parkinson’s – Seeking Alpha” with publication date: November 15, 2018.

Spirit Airlines, Inc. (NYSE:SAVE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.